Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soheil Meshinchi

Showing results (41-50 of 218) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology GroupRobert B Gerbing, Todd A Alonzo, Lillian Sung, et al.
Pharmaceutics|October 23, 2021
Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid LeukemiaPatrick Connerty, Ernest Moles, Charles E de Bock, et al.
Blood|April 19, 2007
The incidence and clinical significance of nucleophosmin mutations in childhood AMLPatrick Brown, Emily McIntyre, Rachel Rau, et al.
Pediatric Blood & Cancer|June 29, 2010
MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology GroupChristine L Phillips, Robert Gerbing, Todd Alonzo, et al.
Pediatric Blood & Cancer|August 20, 2013
The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology GroupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
British Journal of Haematology|July 6, 2013
High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology groupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
Pediatric Blood & Cancer|July 21, 2023
Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasmsTodd M Cooper, Todd A Alonzo, Sarah K Tasian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2014
The outcome of allogeneic hematopoietic cell transplantation for children with FMS-like tyrosine kinase 3 internal tandem duplication-positive acute myelogenous leukemiaTal Schechter, Adam Gassas, Heidi Chen, et al.
NPJ Systems Biology and Applications|March 26, 2024
Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemiaLisa Uechi, Swetha Vasudevan, Daniela Vilenski, et al.
Plos One|November 18, 2021
A B-cell developmental gene regulatory network is activated in infant AMLHamid Bolouri, Rhonda Ries, Laura Pardo, et al.
Pageof 22

Showing results (41-50 of 218) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology GroupRobert B Gerbing, Todd A Alonzo, Lillian Sung, et al.
Pharmaceutics|October 23, 2021
Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid LeukemiaPatrick Connerty, Ernest Moles, Charles E de Bock, et al.
Blood|April 19, 2007
The incidence and clinical significance of nucleophosmin mutations in childhood AMLPatrick Brown, Emily McIntyre, Rachel Rau, et al.
Pediatric Blood & Cancer|June 29, 2010
MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology GroupChristine L Phillips, Robert Gerbing, Todd Alonzo, et al.
Pediatric Blood & Cancer|August 20, 2013
The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology GroupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
British Journal of Haematology|July 6, 2013
High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology groupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
Pediatric Blood & Cancer|July 21, 2023
Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasmsTodd M Cooper, Todd A Alonzo, Sarah K Tasian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2014
The outcome of allogeneic hematopoietic cell transplantation for children with FMS-like tyrosine kinase 3 internal tandem duplication-positive acute myelogenous leukemiaTal Schechter, Adam Gassas, Heidi Chen, et al.
NPJ Systems Biology and Applications|March 26, 2024
Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemiaLisa Uechi, Swetha Vasudevan, Daniela Vilenski, et al.
Plos One|November 18, 2021
A B-cell developmental gene regulatory network is activated in infant AMLHamid Bolouri, Rhonda Ries, Laura Pardo, et al.
Pageof 22